The present work reports on the synthesis, anti-Trypanosoma cruzi activities and docking studies of a novel series of 2-(pyridin-2-yl)-1,3-thiazoles derived from 2-pyridine thiosemicarbazone. The majority of these compounds are potent cruzain inhibitors and showed excellent inhibition on the trypomastigote form of the parasite, and the resulting structureeactivity relationships are discussed. Together, these data present a novel series of thiazolyl hydrazones with potential effects against Chagas disease and they could be important leads in continuing development against Chagas disease.
Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening illness caused by the protozoan parasite Trypanosoma cruzi (T. cruzi) [1] . About 7e8 million people worldwide are estimated to be infected with T. cruzi, mainly in Latin America.
Over the years, numerous chemical classes against T. cruzi have become available, but there is still no effective treatment for all phases of the disease [2] . Recent research has pointed to the ergosterol biosynthetic pathway as a biochemical target [3, 4] . Azole derivatives such as posaconazole and ravuconazole, have been tested and presented trypanocidal activity, but they are not yet available as therapeutics [5e7] .
Despite the efforts of many investigators in the research of a new anti-Chagas drugs, only two drugs are currently used to treat it, nifurtimox and benznidazole [6, 8] (Fig. 1) . Current chemotherapy for Chagas disease is unsatisfactory due to its limited efficacy, particularly in the chronic phase, with frequent side effects that can lead to discontinuation of treatment.
Among a number of drug targets being investigated for Chagas disease, cruzain, the major cysteine protease active in the parasite, is a prominent candidate [9e12] . Cruzain is a cathepsin-L-like protease of the papain family thought to be important for intracellular replication and differentiation of the T. cruzi parasite [13] . Among the chemical groups explored for anti-Chagas activity, thiazolyl hydrazones are noteworthy because of their wide biological, especially anti-parasitic, activities [14e17] .
In 2004, Greenbaum et al. observed that thiosemicarbazones with a pyridyl moiety inhibit cruzain catalytic activity [18] . Subsequent studies have demonstrated the trypanocidal activity of thiosemicarbazones and their metal complexes. Recently, Caputo et al. have demonstrated trypanocidal activity for a series of 4-arylthiazolylhydrazones [19] , with a broad and potent activity for all forms of the parasite. Recently studies have reported inhibition of the cysteine protease cruzain by thiosemicarbazones [16] . Our efforts toward new antichagasic drug since 2010 have led us to a variety of thiosemicarbazones and thiazolyl hydrazones as trypanocidal agents [16,19e22] . The promising results achieved by compounds bearing a thiazole ring motivated us to investigate the trypanocidal activity of novel thiazolyl hydrazones derived from 2-pyridyl thiosemicarbazone, with changes being made in the phenyl ring attached in N2. In continuation of our search for bioactive molecules, we envisaged that the derivatization of the thiosemicarbazone group into thiazole moiety would generate novel templates, which are likely to exhibit anti-T. cruzi activity. We also investigate pyridines as trypanocidal agents because their wide applicability in organic synthesis, low price and facility in synthesis.
Here, these compounds were tested in vitro against T. cruzi parasite epimastigote and trypomastigote forms, and cruzain protease. In this synthetic design of a structureeactivity relationship (SAR) library, attention was paid to further explore substituents around the phenyl ring attached in thiazole ring (C9). This study generated basic SARs about tripomastigote form and cruzain enzyme around substituents in phenyl ring, and using the scaffold shown in Scheme 1. Specifically, we report the preparation of twenty-four 2-(pyridin-2-yl)-1,3-thiazoles (3e27) by ultrasound-assisted synthesis. The synthesized compounds were characterized by IR, NMR and mass spectral studies. The 2-(pyridin-2-yl)-1,3-thiazoles were assayed for their in vitro anti-T. cruzi activity against the epimastigote and trypomastigote forms of the parasite. Their cytotoxicity in mammalian cell cultures was also investigated. Further investigations on the possible involvement of 2-(pyridin-2-yl)-1,3-thiazoles with cruzain activity as potential therapeutic targets were performed.
Results and discussion

Chemistry
2-(pyridin-2-yl)thiosemicarbazones (2aeb) were prepared by reacting commercially available thiosemicarbazides with the appropriate aldehyde or ketone (1:1.2 mol ratio) via Schiff base condensations using ultrasound irradiation in presence of a catalytic amount of AcOH. This reaction condition led to high yields (80e90%). 2-(pyridin-2-yl)-1,3-thiazoles (3e26) were prepared via Hantsch cyclization between 2-(pyridin-2-yl)thiosemicarbazones (2aeb) and substituted 2-bromoacetophenones (Scheme 1). These reactions proceed well upon refluxing with ethanol (2e4 h), but here we adapted this to ultrasound conditions at room temperature [23] using 2-propanol as solvent [24] . This resulted in good yields (50e85%) and shorter reaction times (60 min in most cases) compared with the reflux protocol.
Microanalysis and NMR data are compatible with the proposed compounds. In theory, two geometrical isomers (E and Z) about the imine (C]N) double bond are possible for the thiosemicarbazones. However, analysis of the 1 H NMR spectra of the target compound indicated one predominant isomer; the E isomer by comparison with known analogues [25] . Intramolecular H-bonding involving the proton attached to N4 (in DMSO) with the imine N-atom leads to a distinctive singlet around 10.2 ppm [25] and this is also seen here.
Once thiosemicarbazones were characterized, the respective 2-(pyridin-2-yl)-1,3-thiazoles were characterized by usual spectroscopy. As exemplified with the 1 H NMR analysis of (2-(1-(pyridin-2- 
X-ray crystallography
The X-ray crystal structure of 2-(2-(pyridin-2-ylmethylene) hydrazinyl)-4-(4-tolyl)-1,3-thiazole (4) is shown in Fig. 2 . Crystal and refinement data are summarized in Table 1 . The dihedral angles C(11)eC(10)eC(9)eN(4), C(9)eN(4)eC(7)eN(3), C(7)eN(3)eN(2)e C (6) , N(2)eC(6)eC(5)eC(4) and C(16)eC(13)eC(12)eC(11) of À177.84 , À179.48 , À176.60 , À176.54 and 178.43 respectively indicate that the molecule is close to planar. In the thiazole ring, two significantly different CeN bonds are found viz. C9eN4 (1.373(4) Å) and C7]N4 (1.265(5) Å) and C8]C9 is clearly a double bond (1.348(5) Å). It is apparent that compound (4) crystallises in the Z-isomeric form where intramolecular H-bonding with the pyridyl ring and the proton attached to N2 is seen (see Fig. 2 ). In this case, the E-isomer cannot be stabilised by H-bonding due to the loss of the proton from N 4 of the parent thiosemicarbazone.
Structureeactivity relationships (SAR)
To investigate the importance of substituents on the phenyl ring for the antiparasitic activity against trypomastigote form, compound (3) (without substituents) was compared with seven para substituted analogues. It was found that compounds (5), (6) , (8) and (9) showed better anti-T. cruzi activity than (3), while compounds (4), (7) and (13) were less potent (see Table 2 ). For the chloro substituted compounds (9e11), it was observed that the dichloro compounds (10 and 11) were equally trypanocidal, being 3-fold more potent than 2-(2-(pyridin-2-ylmethylene)hydrazinyl)-4-(4-chlorophenyl)-1,3-thiazole (9) . The monobromo compounds (5) and (6) displayed activity intermediate of the mono and dichloro compounds. The presence of a methyl group attached to C8 (for compound 5) did not significantly affect biological activity.
Comparing compound (14) with (3) (naphthyl and aryl, respectively), it was observed that the influence of a more bulky substituent increased the trypanocidal activity, probably because of an increase in lipophilicity. For the nitro compounds (12) and (13), the position of the substituent affected trypanocidal activity. For compound (12) , (meta substituted), a 2-fold increase in activity was found relative to (13) (para substituted).
Compounds (15) to (26) (derived from 2-acetyl pyridine) differed from compounds (3) to (14) (derived from 2-pyridine carbaldehyde) by a methyl group present in C6 (Scheme 1). Analysis of the activity of these compounds suggests a trend in which a methyl in C6 increases the trypanocidal activity. Compounds (15)e(26) stand out, show high trypanocidal activity (trypomastigote form); with exception of (25) , all compounds are more potent than reference drug benznidazole. (4) showing intramolecular H-bonding (30% probability ellipsoids are shown). The para substituted 2-(pyridin-2-yl)-1,3-thiazoles (16e21 and 25) were less active than unsubstituted (2-(1-(pyridin-2-yl) ethylene)hydrazinyl)-4-phenyl-1,3-thiazole (15) , which was the most potent compound tested in this work. No correlation was observed between the electron withdrawing properties of the substituent and trypanocidal activity.
For the isomeric dichloro compounds (22) and (23), we observed little change in trypanocidal activity. For the nitro compounds (24 and 25) , the compound meta substituted (24) was 9-fold more potent than para substituted (25) , (3.9 mM vs 36.7 mM respectively).
From Table 3 , it can be seen that (2-(pyridin-2-yl)ethylene)-1,3-thiazoles (15e26) (with a methyl attached to C6), had increased the trypanocidal activity for both trypomastigote and epimastigote in comparison with (2-(pyridin-2-yl)methylene)-1,3-thiazoles (3e14).
Comparing compounds with nitro substituents across the (3e14) and (15e26) series, the biggest difference was observed for compounds (13/25) (meta substituted), with 3.9 mM against 74.2 mM and (12/25), para substituted, with 36.7 mM against 152.9 mM.
Among all of the compounds in this work, the most potent were (10), (11) and (15) . It should be noted that among twenty-four compounds designed for anti-Chagas activity, twenty compounds (3, 5, 6, 8e11, 14, 15e24 and 26) displayed better trypanocidal activity than benznidazole.
Analysing the antiparasitic activity against epimastigote form, benznidazole, which is the reference drug, exhibited an IC 50 of 6.6 mM. Once again, the majority of derivatives were very active. In this case, only compounds (6), (20) and (22) were several times less potent than benznidazole. In contrast, compounds (5), (12), (15)e (19) and (21) displayed a better activity profile than benznidazole-treated parasites.
A recent work describing 2-imino-1,3-thiazoles [16] (derivatives 26e46), that share an aryloxypropylimine instead of a pyridine ring, displayed lower trypanocidal effects when compared to these that possess a 2-pyridyl moiety, pointing out the importance of the 2-pyridyl moiety for the trypanocidal activity. Fig. 3 summarizes the main SAR for anti T. cruzi activity (tripomastigote form). Table 4 shows the inhibition of the enzyme cruzain of T. cruzi (TCC). The experimental protocol described by Ferreira [26] was utilized in this assay. All compounds were tested at a concentration of 100 mM, except for cases limited by solubility, in which the screening was performed at either 50 or 75 mM (as noted on Table 4 ). Compounds which inhibited enzyme activity by at least 70% in the screening had their IC 50 determined.
Cruzain inhibition activity
Some works describe that 2-imino-1,3-thiazoles are trypanocidal agents by altering the ergosterol biosynthesis instead of inhibiting the catalytic activity of cruzain [16, 19] . In this work we show that cruzain is potently inhibited by several compounds.
Among all compounds tested, the most actives were (20) and (26), showing the lowest IC 50 values (0.04 ± 0.03 mM and 0.01 mM, respectively). Due to the low potency of some compounds and the absence of IC 50 values, in some cases we made a discussion based in percentual inhibition of cruzain.
Comparing para substituted compounds; the most active were (20) , (16), (19) and (5), showing percentage of inhibition near 90%. (11), which displayed weak inhibition. For the nitro compounds (12e13), the positional change of the nitro group from para to meta had a huge impact on potency against cruzain: while the 2-(2-(pyridin-2- (13) does not considerably inhibit the enzyme at 100 mM.
To investigate the relative activity of thiosemicarbazone vs thiazole in cruzain inhibition, compounds (2a) and (3) were compared. Neither of these compounds inhibits the enzyme at the concentrations evaluated, but (15) , an analogue of (3) differing only by the addition of a methyl group at C6 was shown to be a moderately potent inhibitor IC 50 ¼ 1.3 ± 0.7 mM. Extrapolating the analysis by comparison of compounds (3e14) to compounds (15e26), which show an analogous difference, we observe that in seven cases the addition of the methyl considerably improved cruzain inhibition, while only for two compound pairs (5 vs 17 and 12 vs 24) the opposite effect was observed. Together, these results indicate the high importance of the methyl group at C6.
Within the series (15e26), seven compounds had their IC 50 values determined, and in five cases the potency was better than 0.5 mM. Among the para substituted compounds, (16) and (19) had very similar potencies. On the other hand, modifying the methyl substituent (16) to methoxy (20) increased the potency by an order of magnitude.
For chlorine substituted compounds (21e23), the pattern of substitution had a big impact on potency. While the para substituted compound was inactive, disubstituted compounds were cruzain inhibitors, and the 3,4-diCl compound (23) was 12 fold more potent than the 2,4-diCl (22) . Comparing the isomeric nitro-compounds (meta (24) and para (25) substituted), no significant cruzain inhibition was observed.
Cytotoxicity activity
To determine the toxicity profile of the compounds, cytotoxicity assay adapted from Ballell et al. [27] were performed with HepG2 cells, a human liver cell line commonly used for in vitro testing of toxicity [28] . Cells were incubated with the compounds at concentration of 100 mM for 48 h. It is worth mentioning that a compound that can kill parasites is necessary but not sufficient to represent a good drug lead unless it also demonstrates low or nontoxicity among other criteria. As can be observed in Tables 2 and 3 , only compound (7) (a fluorine derivative) exhibited toxicity for HepG2 (18.20 mM). The most of compounds were less cytotoxic for HepG2 at concentrations up to 85.11 mM, demonstrating the low toxicity profile of the compounds assayed.
Docking studies
In order to understand a probable mechanism of action, we investigated the interaction of these compounds with cruzain (PDB ID: 3IUT) by docking studies. The binding mode for the ligands was determined as the highest (most positive) score among the possible solutions for each ligand, generated according to the CHEMPLP Score Function [29] . Fig. 4 shows the superposition of the best Table 4 Comparison of in vitro cruzain inhibition activity of compounds (2ae2b) and (3e26).
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, (15), (16), (19) , (20), (22), (23) and (26) (blue structures) bound to cruzain (green) and the crystallographic structure of the "KB2" cocrystallized ligand [30] (red structure). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
docking solutions for compounds that have IC 50 values experimentally determined for cruzain (5, 12, 15, 16, 19, 20, 22, 23, 26) and the crystallographic structure of the "KB2", a high-efficient cruzain inhibitor cocrystallized ligand [30] . To compare in silico vs in vitro cruzain data, IC 50 values were first converted into pIC 50 values (equals e log 10 IC 50 for cruzain inhibition, in units of moles per litre). Fig. 5 shows the trend between the calculated docking scores and the experimental pIC 50 data, which indicates the compounds with the highest pIC 50 being most active. There is a clear correlation between the docking score and pIC 50 supporting the hypothesis that the most tightly binding thiazoles are also the most potent cruzain inhibitors (i.e., greater in vitro pIC 50 values).
To identify the molecular reasons for the two extremes of potency, the highest (26) (IC 50 ¼ 0.01 nM) and lowest (5) (IC 50 ¼ 9.5 nM) in vitro results, we performed a detailed analysis of the intermolecular interactions with the cruzain target. The principle structural differences between these two molecules are as follows: (i) the presence of a 4-bromophenyl ring linked to the thiazole ring in molecule (5), instead of a naphthalene group in molecule (26); (ii) a methyl group on C6 (adjacent to the pyridyl ring) for molecule (26) , rather than hydrogen for molecule (5) .
The difference between the binding modes of these two molecules is show in detail in Fig. 6 and Table 5 . It appears that the large hydrophobic naphthalene group in molecule (26) provides a greater contact surface for interactions with hydrophobic residues LEU67, MET68, ALA138 and LEU160 in the S2 cruzain subsite, which is known to accommodate hydrophobic groups. Compared with the bromophenyl group in (5). The hydrogen bond with the residue ASP161 is slightly shorter for the molecule (26) (2.5 Å) than for molecule (5) (2.8 Å). There is also a weak hydrogen bond with the CYS25 residue (3.4 Å). These finding imbue greater stability to the complex formed with (26) than (5), with docking scores of 66.09 and 55.29, respectively. These findings corroborate the in vitro binding assay with the cruzain enzyme.
Conclusion
The current investigation has revealed novel structureeactivity relationships regarding aromatic substitution at the phenyl moiety of 2-(pyridin-
Compounds (10) and (11) were the most potent thiazoles with IC 50 values of 1.2 mM for each compound. In addition, all of the novel thiazoles showed similar or greater trypanocidal efficacy than Benznidazole, with compounds (10) and (11) exhibiting highest efficacies overall. Structureeactivity analysis did not reveal a correlation between ligands with electron-donating or electron-withdrawing substituents in terms of trypanocidal activity. However, the in silico docking studies corroborate with in vitro cruzain inhibition, showing that the molecules with more stable or positive docking scores (i.e., greater in silico affinity for cruzain) are also the most potent cruzain inhibitors (i.e., greater in vitro pIC 50 values).
Experimental section
Equipment and reagents
All reagents were used as purchased from commercial sources (SigmaeAldrich, Acros Organics, Vetec or Fluka). Progress of the reactions was followed by thin-layer chromatography (TLC) analysis (Merck, silica gel 60 F 254 in aluminium foil). Purity of the target compounds was confirmed by combustion analysis (for C, H, N, S) performed by a Carlo-Erba instrument (model EA 1110). Melting points were determined on a Fisatom 430D electrothermal capillary melting point apparatus and were uncorrected. NMR spectra were measured on either a Varian UnityPlus 400 MHz (400 MHz for (5), (12), (15), (16), (19) , (20), (22), (23) and (26) . 
Crystallography
Crystallographic data were collected on an Oxford Diffraction Gemini S Ultra CCD diffractometer at 296 K using MoKa radiation (2q max ¼ 50 ). Data reduction and empirical absorption corrections were carried out with the CrysAlis Pro program (Oxford Diffraction vs 171.33.42). The structure was solved by direct methods with SHELXS86 and refined with SHELXL97 [31] . All non-H-atoms were refined anisotropically and H-atoms were constrained at their estimated positions using a riding model. The thermal ellipsoid diagram was generated with ORTEP3 [32] . All crystallographic calculations were carried out within the WinGX graphical user interface [33] . Crystallographic data of compound (4) have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication CCDC 980106. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre ((Cambridge, UK) via www.ccdc.cam.ac.uk).
General modified procedure for the synthesis of known thiosemicarbazones (2aeb)
To a solution of 2-pyridine carbaldehyde (0.75 g, 7 mmol) (or acetyl-2-pyridine (0.85 g, 7 mmol)) in 2-propanol (10 mL) was added thiosemicarbazide (0.64 g, 7 mmol) and few drops of acetic acid. The reaction vessel was placed in an ultrasonic bath (40 MHz, 180 V) and irradiated for 120 min, at r.t. The precipitate was filtered off, washed with hexane then dried in desiccator under vacuum. Additional amount of desired compound could be recovered from the filtrate after cooling.
2-(Pyridin-2-ylmethylene)hydrazinecarbothioamide (2a)
Crystallization from toluene/hexane 7:3, afforded yellow crystals, yield: 91%. 
General procedure for the synthesis of (3e26). Example for compound (3)
2-(Pyridin-2-ylmethylene)hydrazinecarbothioamide (2a) (0.5 g, 2.78 mmol) was dissolved in 2-propanol (10 mL) and then the appropriate 2-bromoacetophenone (see Scheme 1) (0.79 g, 3.05 mmol) and calcium carbonate (0.42 g, 3.05 mmol) were added to a glass tube. The tube was placed in an ultrasonic bath (40 MHz, 180 V) and irradiated for 60 min, at r.t. Hexane was added and the mixture was cooled in a freezer overnight. The precipitate was filtered off and washed with hexane then dried in a desiccator under vacuum. Additional amount of the desired compound were obtained from the filtrate after cooling. Pure products were obtained after recrystallization using the solvent system detailed below for each compound.
2-(2-(Pyridin-2-ylmethylene)hydrazinyl)-4-phenyl-1,3-thiazole (3)
Crystallization from toluene/hexane 7:3, afforded yellow crystals. Yield: 86%, m.p. ( C 
Cytotoxicity for HepG2
The HepG2 cytotoxicity assay was adapted from Ballell et al. [27] . Actively growing HepG2 cells were removed from a T-175 TC flask using supplemented Eagle's MEM and plated at a density of 3000 cells/well into the 384-well clear-bottom plates using a Multidrop instrument. Prior to addition of the cell suspension, the screening compounds (250 nL) were dispensed into the plates with an Echo 555 instrument. Plates were allowed to incubate at 37 C at 80% relative humidity for 48 h under 5% CO 2 . The signal developer, CellTiter-Glo (Promega) was added to the plates using a Multidrop and the plates were read using a ViewLux instrument (PerkinElmer).
Antiproliferative activity for epimastigotes
Epimastigotes were counted in a hemocytometer and then dispensed into 96-well plates at a cell density of 10 6 cells/well. Test inhibitors, dissolved in DMSO, were diluted into five different concentrations (1.23, 3.70, 11.11, 33.33 , and 100 mg/mL) and added to the respective wells in triplicate. The plate was incubated for 11 days at 26 C, and aliquots of each well were collected and the number of viable parasites were counted in a Neubauer chamber, and compared to untreated parasite culture. IC 50 values were calculated using non-linear regression on Prism 4.0 GraphPad software. This experiment was done in duplicate, and Benznidazole (LAFEPE, Brazil) were used as the reference inhibitors.
Toxicity for Y strain trypomastigotes
Trypomastigotes collected from the supernatant of LLC-MK 2 cells were dispensed into 96-well plates at a cell density of 4 Â 10 5 cells/well. Test inhibitors, dissolved in DMSO, were diluted into five different concentrations and added into their respective wells, and the plate was incubated for 24 h at 37 C and 5% of CO 2 . Aliquots of each well were collected and the number of viable parasites, based on parasite motility, was assessed in a Neubauer chamber. The percentage of inhibition was calculated in relation to untreated cultures. IC 50 calculation was also carried out using nonlinear regression with Prism 4.0 GraphPad software. Benznidazole was used as the reference drug.
Docking studies
The structures of all compounds were obtained by application of the RM1 [34] method, available as part of the SPARTAN 08' program [35] , using internal default settings for convergence criteria. Docking calculations and analysis was carried using the T. cruzi cruzain (PDB ID code: 3IUT) as the target [30] , in which there was a cocrystallized complex with an inhibitor (referred to as "KB2"). The active site was defined as all atoms within a radius of 6.0 Å from this cocrystallized ligand. The residues GLN19, CYS25, SER61, LEU67, MET68, ASN70, ASP161, HIS162, TRP184 and GLU208 were treated as flexible. The GOLD 5.1 program [36] was used for docking calculations, followed by Binana program [37] , which was used to analyse the molecular interactions present in the best docking solutions, using default setting, except for hydrogen bond distance (changed to a maximum of 3.5 Å). Figures were generated with Pymol [38] .
